schizophrenia

News and resources

Apr 06 2026

Schizophrenia Study Finds New Biomarker, Drug Candidate to Treat Cognitive Symptoms – Northwestern University

by Clinical Editor

No Comments

Schizophrenia Study Finds New Biomarker, Drug Candidate to Treat Cognitive Symptoms Northwestern University

Apr 06 2026

Severe Nondiabetic Hypoglycemia After Risperidone Initiation in an Adult With Schizophrenia: A Case Report and Systematic Review – Cureus

by Clinical Editor

No Comments

Severe Nondiabetic Hypoglycemia After Risperidone Initiation in an Adult With Schizophrenia: A Case Report and Systematic Review Cureus

Apr 05 2026

Alto halts work on PDE4 inhibitor after ph. 2 schizophrenia fail – Fierce Biotech

by Clinical Editor

No Comments

Alto halts work on PDE4 inhibitor after ph. 2 schizophrenia fail Fierce Biotech

Apr 05 2026

Groundbreaking Study Reveals Schizophrenia, Bipolar Disorder, and Anorexia Share Genetic Roots – Iowa Park Leader

by Clinical Editor

No Comments

Groundbreaking Study Reveals Schizophrenia, Bipolar Disorder, and Anorexia Share Genetic Roots Iowa Park Leader

Apr 04 2026

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia – Medscape

by Clinical Editor

No Comments

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia Medscape

Apr 04 2026

Shortage of synapses predicts severity of cognitive impairment in schizophrenia, study reveals

by Clinical Editor

No Comments

Schizophrenia is a severe mental disorder affecting about 1% of the population worldwide, and is notoriously difficult to treat. Current treatments successfully target the disorder’s positive symptoms …

Apr 03 2026

Alto halts work on PDE4 inhibitor after phase 2 schizophrenia failure

by Clinical Editor

No Comments

Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with t …

Apr 03 2026

A gene mutation may trap the brain in the wrong reality in schizophrenia patients

by Clinical Editor

No Comments

A newly identified gene mutation may help explain why schizophrenia patients struggle to update their understanding of reality. The mutation disrupts a brain circuit involved in flexible decision-making, causing mice...

Apr 02 2026

Alto Neuroscience Misses Primary Endpoint in Schizophrenia Drug Study

by Clinical Editor

No Comments

Alto Neuroscience missed the primary endpoint for a study of its ALTO-101 drug for the treatment of cognitive impairment associated with schizophrenia.

Apr 02 2026

4 Ways to Find the Support You Need While Caring for a Person With Schizophrenia

by Clinical Editor

No Comments

Caring for a friend or loved one with schizophrenia can often feel all-consuming. You may find yourself sacrificing work, school, or downtime during moments of crisis. Remaining hours, meanwhile, are...